ELI LILLY & Co
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Neuroscience — Worldwide revenue [legacy total] by Year
Neuroscience — Worldwide revenue ($M) [legacy total] ($M)
Eli Lilly Neuroscience — Worldwide revenue [legacy total]: $2,171M in FY2017, down 20.2% from a year earlier. No newer figure appears in the documents we track.
Where the FY2017 figure comes from
Source: Form 10-K (filed 2018-02-20) ↗
Reported in Form 10-Q / 10-K Note 2.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Neuroscience — Worldwide revenue ($M) [legacy total] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2017 | Dec 31, 2017 | 2,171 | -20.2% | Form 10-K (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | 2,720 | -7.3% | Form 10-K (filed 2018-02-20) ↗ |
| FY2015 | Dec 31, 2015 | 2,935 | -18.4% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 3,597 | -50.2% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 7,216 | -4.7% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 7,575 | -22.1% | Form 10-K (filed 2014-02-19) ↗ |
| FY2011 | Dec 31, 2011 | 9,724 | – | Form 10-K (filed 2014-02-19) ↗ |
Cite this data
StockData. (2026). Eli Lilly Neuroscience — Worldwide revenue [legacy total] ($M), annual FY2011–FY2017 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/ta-neuroscience-ww-legacy
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.